Full Text View
Tabular View
No Study Results Posted
Related Studies
Study Evaluating Drug Interaction Between Multiple Doses of Ketoconazole and a Single Dose of SKI-606
This study has been completed.
First Received: February 9, 2007   Last Updated: September 10, 2007   History of Changes
Sponsor: Wyeth
Information provided by: Wyeth
ClinicalTrials.gov Identifier: NCT00434486
  Purpose

To investigate a potential pharmacokinetic interaction between SKI-606 and ketoconazole when co-administered.


Condition Intervention Phase
Healthy
Drug: SKI-606
Phase I

Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Uncontrolled, Crossover Assignment, Pharmacokinetics Study
Official Title: An Open-Label, Randomized, 2-Period Crossover Study to Evaluate the Potential Pharmacokinetic Interaction Between Multiple Doses of Ketoconazole and a Single Dose of SKI-606 Administered Orally to Healthy Subjects

Resource links provided by NLM:


Further study details as provided by Wyeth:

Primary Outcome Measures:
  • Pharmacokinetics; safety and tolerability

Estimated Enrollment: 24
Study Start Date: March 2007
Estimated Study Completion Date: March 2007
  Eligibility

Ages Eligible for Study:   18 Years to 50 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Healthy as determined by the investigator on the basis of medical history, physical examination, clinical laboratory test results, vital signs, and 12-lead ECG.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00434486

Locations
United States, Pennsylvania
Philadelphia, Pennsylvania, United States, 19148
Sponsors and Collaborators
Wyeth
Investigators
Study Director: Medical Monitor Wyeth
  More Information

No publications provided

Study ID Numbers: 3160A4-104
Study First Received: February 9, 2007
Last Updated: September 10, 2007
ClinicalTrials.gov Identifier: NCT00434486     History of Changes
Health Authority: United States: Food and Drug Administration

Additional relevant MeSH terms:
Anti-Infective Agents
Therapeutic Uses
Antifungal Agents
Ketoconazole
Pharmacologic Actions

ClinicalTrials.gov processed this record on February 08, 2010